Clinical trials
Phase 1 Spondylitis, Ankylosing trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celltrion | 2 |
| UCB BIOSCIENCES, Inc. | 2 |
| Asia Cell Therapeutics (Shanghai) Co., Ltd. | 1 |
| Biocad | 1 |
| Centocor, Inc. | 1 |
| Eighth Affiliated Hospital, Sun Yat-sen University | 1 |
| Fresenius Kabi SwissBioSim GmbH | 1 |
| Hospital District of Helsinki and Uusimaa | 1 |
| Kinevant Sciences GmbH | 1 |
| Laboratorios Richmond S.A.C.I.F. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spondylitis, Ankylosing | 16 |
| Arthritis, Psoriatic | 6 |
| Arthritis, Rheumatoid | 5 |
| Crohn Disease | 4 |
| Axial Spondyloarthritis | 3 |
| Arthritis, Juvenile | 2 |
| Autoimmune Diseases | 2 |
| Colitis, Ulcerative | 2 |
| Hidradenitis Suppurativa | 2 |
| Disease | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.